OrthoPediatrics (NASDAQ:KIDS – Get Free Report) will release its earnings data after the market closes on Wednesday, November 6th. Analysts expect OrthoPediatrics to post earnings of ($0.12) per share for the quarter. Persons interested in participating in the company’s earnings conference call can do so using this link.
OrthoPediatrics (NASDAQ:KIDS – Get Free Report) last issued its quarterly earnings results on Monday, August 5th. The company reported ($0.23) earnings per share for the quarter, topping the consensus estimate of ($0.31) by $0.08. OrthoPediatrics had a negative net margin of 14.35% and a negative return on equity of 5.44%. The company had revenue of $52.80 million for the quarter, compared to the consensus estimate of $52.40 million. On average, analysts expect OrthoPediatrics to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.
OrthoPediatrics Price Performance
Shares of NASDAQ:KIDS opened at $26.59 on Wednesday. OrthoPediatrics has a twelve month low of $23.51 and a twelve month high of $36.23. The company’s 50 day moving average is $28.37 and its 200 day moving average is $29.96. The company has a current ratio of 4.90, a quick ratio of 1.96 and a debt-to-equity ratio of 0.03. The company has a market cap of $633.61 million, a PE ratio of -27.70 and a beta of 1.17.
Insiders Place Their Bets
Analysts Set New Price Targets
Several equities analysts recently weighed in on KIDS shares. Truist Financial cut their price target on shares of OrthoPediatrics from $34.00 to $28.00 and set a “hold” rating on the stock in a report on Monday, October 14th. JMP Securities reiterated a “market outperform” rating and issued a $50.00 price target on shares of OrthoPediatrics in a report on Friday, September 13th. Finally, Needham & Company LLC restated a “buy” rating and issued a $42.00 price objective on shares of OrthoPediatrics in a research report on Friday, September 13th.
View Our Latest Stock Analysis on OrthoPediatrics
About OrthoPediatrics
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.
Featured Articles
- Five stocks we like better than OrthoPediatrics
- What Investors Need to Know to Beat the Market
- 2 Small Modular Reactor Stocks Racing to Power AI Data Centers
- What Are Dividend Champions? How to Invest in the Champions
- Oklo Stock: Nuclear Powerhouse or Radioactive Hype?
- What Does Downgrade Mean in Investing?
- Is McDonald’s Stock a Smart Buy After Sell-Off and Earnings?
Receive News & Ratings for OrthoPediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrthoPediatrics and related companies with MarketBeat.com's FREE daily email newsletter.